Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 2853-2857

  Hall, E R ^a   Wierzba, T F ^a   Ahren C ^a   Rao, M R ^a   Bassily, S ^a   Francis, W ^a   Girgis, F Y ^a   Safwat, M ^a   Lee, Y J ^a   Svennerholm, A M ^a   Clemens, J D ^a   Savarino, S J ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CHOLERA TOXIN B SUBUNIT; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED VACCINE; PLACEBO;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FIMBRIA; HUMAN; IMMUNE RESPONSE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; VACCINATION;

ADMINISTRATION, ORAL; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; CHOLERA TOXIN; ESCHERICHIA COLI; FIMBRIAE PROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MIDDLE AGED; VACCINES, SYNTHETIC;

EID: 0035061094     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.2853-2857.2001     Document Type: Article

References (21)

1. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood
2. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine
3. Colonization factors of enterotoxigenic Escherichia coli in children with diarrhea in Argentina
4. The epidemiology of diarrheal disease: Implications for control by vaccines
5. Colonization factors associated with enterotoxigenic Escherichia coli isolated in Thailand
6. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: Results of a large-scale field trial
7. B subunit-whole cell and whole cell-only oral vaccines against cholera: Studies on reactogenicity and immunogenicity
8. Serologic responses to somatic O and colonization factor antigens of enterotoxigenic Escherichia coli in travelers
9. Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without colonization factor antigens
10. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli vaccine
11. Saliva, breast milk, and serum antibody responses as indirect measure of intestinal immunity after cholera vaccination and natural disease
12. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine
13. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children
14. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli cholera toxin B subunit vaccine in Egyptian adults
15. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: Results of the initial evaluation in children. PRIDE Study Group
16. Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area
17. Oral inactivated vaccines against enterotoxigenic Escherichia coli
18. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes
19. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli
20. Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees
21. Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East